Skip to main content

Table 1 The used PBPK modelling parameters for ROF and ROF N-oxide

From: Prediction of drug–drug interactions between roflumilast and CYP3A4/1A2 perpetrators using a physiologically-based pharmacokinetic (PBPK) approach

Parameters (Units)

Values

Source and comments

ROF

ROF N-oxide

MW(g·mol−1)

403.21

419.21

Chemspider

pKa (Base)

13.3 (acid); 2.4 (base)

12.92, 0.65

[9], Optimized for ROF N-oxide

LogP

3.5

2.6

Optimized

Solubility (μg·mL−1)

0.5 (@pH7.4)

-

[9]

Papp (X 10–5 cms−1)

0.01

-

[20]

fup

0.011

0.034

[9]

Rbp

0.73

0.62

Calculated by PK-Sim

CYP3A4 CLint,u (μL/min/mg)a

0.90/0.55

0.010/0.0093

Optimized based on the observed human PK

CYP1A2 CLint,u (μL/min/mg)a

0.55/0.33

-

Calculated based on lower clearance in COPD patients

CLa (μL/min/mg)a

-

0.10/0.093

CLR(L/h)

GFR*fup

Default

GFR fraction

1.0

Default

KIns,p scale

5.0

-

Optimized based on the observed human PK

Partition coefficients

Rodgers and Rowland

Optimized based on the observed human PK

Cellular permeabilities

PK-Sim Standard

Concentration (μM/L liver tissue)

 CYP3A4

4.32

Default

 CYP1A2

1.80

Abundance in HLM (pmol/mg protein)

 CYP3A4

137

[21]

 CYP1A2

52

kdeg

 CYP3A4

0.019 h−1(liver),0.03 h−1 (intestine)

[22]

 CYP1A2

0.017 h−1(liver), 0.03 h−1 (intestine)

Ki CYP3A4 (μM)

2.79

-

[9]

  1. -No data, MW Molecular weight, pKa Dissociation constant, Log P Lipophilicity, Papp Caco-2 cell permeability, fup Unbound fraction in plasma, Rbp Blood-to-plasma concentration ratio, CYP3A4/1A2 CLint,u unbound intrinsic clearance, CLa Additional clearance, CLR Renal clearance, GFR fraction Fraction of filtered drug in the urine, GFR Glomerular filtration rate, KIns,p interstitial-to-plasma partition coefficient, kdeg turnover of the metabolizing enzyme, Ki Concentration resulting in a 50% inhibition
  2. aValues in healthy subjects and COPD patients, respectively